Also, MCM7 is among the known biomarkers for cancer development that are targets for therapies.[41] Given the set of differentially expressed genes, we identify those belonging to the largest connected component of a gene co‐expression network, and then perform pathway enrichment analysis with the GSEApy to infer which biological processes are significantly varying between the healthy tissue and the pre‐cancer, as shown in Figure 4e. This evidence concerns the gene MCM7 and cancer.